News

Teva Pharma has posted a net income of $800m for the second quarter 2010, or $ 0.88 per diluted share, compared to $523m or $0.58 per diluted share

Before being appointed in NexMed Dr Hachicha worked as a senior principal scientist in the pharmacology and drug discovery department at Forest Laboratories, from 2005 to 2010, where

PPD and Microsoft said that the technology will be based on Microsoft Amalga Unified Intelligence System (UIS) and Microsoft HealthVault. Microsoft said that its UIS is a data

Perrigo said that Cherry joins the currently available grape flavor cetirizine syrup in product portfolio, giving patients a choice of store brand flavors. Perrigo claimed that Cetirizine Cherry

Karen is expected to be responsible for small molecule drug discovery in oncology, virology and inflammation at Roche’s Nutley facility. Additionally, She will oversee Nutley discovery chemistry management

Hospira said that Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy. The controlled, randomised trial of patients on hemodialysis who have already been

GSK said that Arixtra is an anti-clotting drug (antithrombotic) which is indicated for the treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis (SVT) of the lower limbs

Revenue of the specialty chemicals booked double-digit revenue growth of 14%, mainly driven by higher volumes. EBITDA for the second quarter was EUR614m, 21% higher than in 2009,

Cellceutix said that KM-133 is also an attractive compound as it may be eligible for an abridged FDA approval process that would allow the compound to go directly